Development of screening systems for drugs against human papillomavirus- associated cervical cancer: Based on E6-E6AP binding

Antiviral Research

Volumn 47, Issue 3, 2000, Pages 199-206

  Cho, Young Sik ^a   Cho, Cheong Weon ^a   Joung, Ok ^a   Lee, Kyung Ae ^a   Park, Sue Nie ^a   Yoon, Do Young ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

E6AP; ELISA; HPV

Indexed keywords

CELL PROTEIN; COMPLEMENTARY DNA; PROTEIN P53; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; DRUG RESEARCH; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE OVEREXPRESSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS ONCOGENE;

BLOTTING, WESTERN; DRUG SCREENING ASSAYS, ANTITUMOR; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIGASES; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PROTEIN BINDING; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEIN P53; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS;

EID: 0033818726     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(00)00109-1     Document Type: Article

References (16)

1. Beerheide W., Bernard H.U., Tan Y.J., Ganesan A., Rice W.G., Ting A.E. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. J. Natl. Cancer Inst. 91(14):1999;1211-1220.
2. Chen J.J., Reid C.E., Band V., Androphy E.J. Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science. 269(5223):1995;529-531.
3. Crusius K., Kaszkin M., Kinzel V., Alonso A. The human papillomavirus type 16 E5 protein modulates phospholipase C-gamma-1 activity and phosphatidyl inositol turnover in mouse fibroblasts. Oncogene. 18:1999;6714-6718.
4. de Villiers E.M. Heterogeneity of the human papillomavirus group. J. Virol. 63:1989;4898-4903.
5. Filatov L., Golubovskaya V., Hurt J.C., Byrd L.L., Phillips J.M., Kaufmann W.K. Chromosomal instability is correlated with telomere erosion and inactivation of G2 checkpoint function in human fibroblasts expressing human papillomavirus type 16 E6 oncoprotein. Oncogene. 16:1998;1825-1838.
6. Howley P.M. Papillomavirinae: the viruses and their replication. Knipe D.M., Howley P.M. Field's Virology. 1996;2045-2076 Lippincott-Raven, Philadelphia, PA.
7. Huibregtse J.M., Scheffner M., Howley P.M. Localization of the E6AP regions that direct human papillomavirus E6 binding, association with p53, and ubiquitination of associated proteins. Mol. Cell. Biol. 13:1993;4918-4927.
8. Marchuk D., Drumm M., Saulino A., Collins F.S. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res. 19(5):1990;1154.
9. Sherman, L., Jackman, A., Itzhaki, H., Stopper, M.C., Koval, D., Schlegel, R., 1997. Inhibition of serum- and calcium-induced differentiation of human keratinocytes by HPV16 E6 oncoprotein: role of p53 inactivation. Virology 237, 296-306.
10. Stellato G., Nieminen P., Aho M., Lehtinen T., Lehtinen M., Paavonen J. Type 1 cytokine response and treatment outcome of genital HPV lesions. Genitourin Med. 73:1997;387-390.
11. Syrjanen S.M., Syrjanen K.J. New concepts on the role of human papillomavirus in cell cycle regulation. Ann. Med. 31:1999;175-187.
12. Tong X., Howley P.M. The bovine papillomavirus E6 oncoprotein interacts with paxillin and disrupts the actin cytoskeleton. Proc. Natl. Acad. Sci. USA. 94(9):1997;4412-4417.
13. Trobs R., Metzner G., Friedrich T., Pustowoit B., Handrick W., Nestler I. Papillomavirus-induced genital warts in a girl - management by surgery and immunomodulating therapy. Pediatr. Surg. Int. 13:1998;301-303.
14. zur Hausen H., de Villiers E.M. Human papilloma viruses. Annu. Rev. Microbiol. 48:1994;427-447.
15. zur Hausen, H., Schneider, A., 1987. The role of papillomaviruses in human anogenital cancers. In: Howley, P.M., Salzman, N.P. (Eds.), The Papovavirinae: The Paillomaviruses. Plenum, New York, pp. 245-263.
16. Zwerschke W., Jansen-Durr P. Cell transformation by the E7 oncoprotein of human papillomavirus type 16: interactions with nuclear and cytoplasmic target proteins. Adv. Cancer Res. 78:2000;1-29.